In a mice NAFLD model, L‐carnitine alleviated hepatic inflammation and fibrosis by inhibiting NF‐κB p65 in a PPARγ‐dependent manner.58 The gene discussed is PPARG; the disease is metabolic dysfunction-associated steatotic liver disease.